cytarabine and cathepsin g

cytarabine has been researched along with cathepsin g in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bridger, G; DiPersio, JF; Holt, MS; Ley, TJ; Nervi, B; Piwnica-Worms, D; Prior, JL; Ramirez, P; Rettig, MP; Ritchey, JK; Uy, GL	1
Azevedo, EA; Coelho-Silva, JL; Franca, RF; Franca-Neto, PL; Hemmelgarn, BT; Krause, A; Lange, AP; Lucena-Araujo, AR; Morais-Sobral, MC; Paiva, HH; Pereira-Martins, DA; Rego, EM; Scheucher, PS; Silva, CL; Thomé, C	1

Other Studies

2 other study(ies) available for cytarabine and cathepsin g

Article	Year
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood, 2009, Jun-11, Volume: 113, Issue:24 Topics: Animals; Anti-HIV Agents; Antimetabolites, Antineoplastic; Apoptosis; Benzylamines; Bone Marrow; Cathepsin G; Cathepsins; Colony-Forming Units Assay; Cyclams; Cytarabine; Drug Synergism; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Leukemia, Experimental; Leukemia, Promyelocytic, Acute; Mice; Mice, Inbred C57BL; Protein Transport; Receptors, CXCR4; Serine Endopeptidases; Stromal Cells; Tumor Cells, Cultured	2009
ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype. Oncotarget, 2017, Jan-31, Volume: 8, Issue:5 Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Bone Marrow Transplantation; Cathepsin G; Cell Differentiation; Cell Proliferation; Cell Self Renewal; Cell Transformation, Neoplastic; Cells, Cultured; Cytarabine; Gene Expression Regulation, Leukemic; Genetic Predisposition to Disease; Leukemia; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Neoplastic Stem Cells; Phenotype; Promyelocytic Leukemia Protein; Retinoic Acid Receptor alpha; Signal Transduction; Time Factors; Transfection; Tumor Protein p73; Up-Regulation	2017

Article

Year

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

Blood, 2009, Jun-11, Volume: 113, Issue:24

Topics: Animals; Anti-HIV Agents; Antimetabolites, Antineoplastic; Apoptosis; Benzylamines; Bone Marrow; Cathepsin G; Cathepsins; Colony-Forming Units Assay; Cyclams; Cytarabine; Drug Synergism; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Leukemia, Experimental; Leukemia, Promyelocytic, Acute; Mice; Mice, Inbred C57BL; Protein Transport; Receptors, CXCR4; Serine Endopeptidases; Stromal Cells; Tumor Cells, Cultured

2009

ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype.

Oncotarget, 2017, Jan-31, Volume: 8, Issue:5

Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Bone Marrow Transplantation; Cathepsin G; Cell Differentiation; Cell Proliferation; Cell Self Renewal; Cell Transformation, Neoplastic; Cells, Cultured; Cytarabine; Gene Expression Regulation, Leukemic; Genetic Predisposition to Disease; Leukemia; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Neoplastic Stem Cells; Phenotype; Promyelocytic Leukemia Protein; Retinoic Acid Receptor alpha; Signal Transduction; Time Factors; Transfection; Tumor Protein p73; Up-Regulation

2017